FNGII (BioActive Nutritional)
Welcome to the PulseAid listing for the FNG drug offered from BioActive Nutritional. This Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | BioActive Nutritional |
NON-PROPRIETARY NAME: | Echinacea, Hydrastis Canadensis, Lomatium Dissectum, Nasturtium Aquaticum, Tabebuia Impetiginosa, Iodium, Adrenalinum, Argentum Metallicum, Thymus (suis), Thyroidinum (suis), Phosphoricum Acidum, Cand |
SUBSTANCE NAME: | ECHINACEA, UNSPECIFIED; GOLDENSEAL; LOMATIUM DISSECTUM ROOT; NASTURTIUM OFFICINALE; TABEBUIA IMPETIGINOSA BARK; IODINE; EPINEPHRINE; SILVER; SUS SCROFA THYMUS; SUS SCROFA THYROID; PHOSPHORAMIDIC ACID; |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2012-09-27 |
END MARKETING DATE: | 2018-09-27 |
FNG II HUMAN PRESCRIPTION DRUG Details:
Item Description | FNG II from BioActive Nutritional |
LABELER NAME: | BioActive Nutritional |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3; 3; 3; 3; 3; 6; 8; 8; 8; 8; 12; 12; 30; 30; 30([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL) |
START MARKETING DATE: | 2012-09-27 |
END MARKETING DATE: | 2018-09-27 |
PRODUCT ID: | 43857-0081_95c41f2a-9c4d-4b40-bfc5-0d9612803b1c |
PRODUCT NDC: | 43857-0081 |
APPLICATION NUMBER: | |
Other ECHINACEA, UNSPECIFIED; GOLDENSEAL; LOMATIUM DISSECTUM ROOT; NASTURTIUM OFFICINALE; TABEBUIA IMPETIGINOSA BARK; IODINE; EPINEPHRINE; SILVER; SUS SCROFA THYMUS; SUS SCROFA THYROID; PHOSPHORAMIDIC ACID; Pharmaceutical Manufacturers / Labelers: